Tranexamic Acid Versus Blood Stopper Treatments in Epistaxis Management

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

186

Participants

Timeline

Start Date

October 31, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

December 31, 2025

Conditions

Epistaxis Nosebleed

Interventions

DRUG

Blood Stopper (Ankaferd)

5 ml of Ankaferd® will be sprayed through the bleeding side nostril and external nasal pressure will be performed for 10 minutes.

All Listed Sponsors

lead

Ankara Ataturk Sanatorium Training and Research Hospital

OTHER_GOV

NCT06490653 - Tranexamic Acid Versus Blood Stopper Treatments in Epistaxis Management | Biotech Hunter | Biotech Hunter